Anti-FUZ monoclonal antibody

Pre-made anti-FUZ monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FUZ/FUZ products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0873-Ab-1/ GM-Tg-hg-IP0873-Ab-2Anti-Human FUZ monoclonal antibodyHuman
GM-Tg-rg-IP0873-Ab-1/ GM-Tg-rg-IP0873-Ab-2Anti-Rat FUZ monoclonal antibodyRat
GM-Tg-mg-IP0873-Ab-1/ GM-Tg-mg-IP0873-Ab-2Anti-Mouse FUZ monoclonal antibodyMouse
GM-Tg-cynog-IP0873-Ab-1/ GM-Tg-cynog-IP0873-Ab-2Anti-Cynomolgus/ Rhesus macaque FUZ monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0873-Ab-1/ GM-Tg-felg-IP0873-Ab-2Anti-Feline FUZ monoclonal antibodyFeline
GM-Tg-cang-IP0873-Ab-1/ GM-Tg-cang-IP0873-Ab-2Anti-Canine FUZ monoclonal antibodyCanine
GM-Tg-bovg-IP0873-Ab-1/ GM-Tg-bovg-IP0873-Ab-2Anti-Bovine FUZ monoclonal antibodyBovine
GM-Tg-equg-IP0873-Ab-1/ GM-Tg-equg-IP0873-Ab-2Anti-Equine FUZ monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0873-Ab-1/ GM-Tg-hg-IP0873-Ab-2; GM-Tg-rg-IP0873-Ab-1/ GM-Tg-rg-IP0873-Ab-2;
GM-Tg-mg-IP0873-Ab-1/ GM-Tg-mg-IP0873-Ab-2; GM-Tg-cynog-IP0873-Ab-1/ GM-Tg-cynog-IP0873-Ab-2;
GM-Tg-felg-IP0873-Ab-1/ GM-Tg-felg-IP0873-Ab-2; GM-Tg-cang-IP0873-Ab-1/ GM-Tg-cang-IP0873-Ab-2;
GM-Tg-bovg-IP0873-Ab-1/ GM-Tg-bovg-IP0873-Ab-2; GM-Tg-equg-IP0873-Ab-1/ GM-Tg-equg-IP0873-Ab-2
Products NameAnti-FUZ monoclonal antibody
Formatmab
Target NameFUZ
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FUZ monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0873-Ag-1Recombinant multi-species FUZZY/ FUZ/ CPLANE3 protein


    Target information

    Target IDGM-IP0873
    Target NameFUZ
    Gene ID80199,70300,308577,719442,476409,101094308,528818,100052158
    Gene Symbol and Synonyms2600013E07Rik,b2b1273Clo,CPLANE3,FUZ,FY,NTD,RGD1310608
    Uniprot AccessionQ9BT04,Q3B756
    Uniprot Entry NameFUZZY_HUMAN,FUZZY_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000010361
    Target ClassificationN/A

    The target: FUZ, gene name: FUZ, also named as CPLANE3, FY, NTD. This gene encodes a planar cell polarity protein that is involved in ciliogenesis and directional cell movement. Knockout studies in mice exhibit neural tube defects and defective cilia, and mutations in this gene are associated with neural tube defects in humans. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.